Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition-Reference-Cited by-同舟云学术

Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition

Published:2019-10-01 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Zhang Hui¹,Lin Yanjun¹,Ma Yiwen²,Zhang Junfeng¹,Wang Changqian¹,Zhang Huili¹

Affiliation:

1. Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, P.R. China

2. Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of organosulfur compounds in pulmonary hypertension;PharmaNutrition;2024-03

2. Hydrogen sulfide attenuates atherosclerosis induced by low shear stress by sulfhydrylating endothelium NFIL3 to restrain MEST mediated endothelial mesenchymal transformation;Nitric Oxide;2024-01

3. Current Status and Future Prospects of Hydrogen Sulfide Donor‐Based Delivery Systems;Advanced Therapeutics;2023-03-22

4. Jagged/Notch proteins promote endothelial‐mesenchymal transition‐mediated pulmonary arterial hypertension via upregulation of the expression of GATAs;Journal of Cellular and Molecular Medicine;2023-03-20

5. Nanomedicine-based treatment: An emerging therapeutical strategy for pulmonary hypertension;Nano Research;2023-02-15